Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | BMC Cancer

Figure 4

From: Androgenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic review

Figure 4

Overall Survival According to Treatment Duration Meta-analysis. Meta-analysis of overall survival, comparing hormone therapy combined with radiotherapy versus radiotherapy alone in patients with non-metastatic prostate cancer, according to the time of hormone treatment (up to 6 months versus one year or more). Abbreviations: CI = confidence interval; HT--hormone therapy; IV = Generic Inverse Variance; RT--radiotherapy; SE = standard error.

Back to article page